AstraZeneca PLC announced that it has won a new purchase order for its beryllium-aluminum alloy products from Lockheed Martin, the maker of the F-35 Lightning II aircraft and many other defense systems. The value of the new order is approximately $7.38 million, which the Company expects to fulfill in 2023 and 2024. IBC also announced that it is currently exploring strategic options with potential partners, investors, and others with regard to its Massachusetts-based Engineered Materials Division, which produces beryllium-aluminum alloy components for defense and commercial applications, including potential joint ventures, a restructuring, a sale, or other options.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 CAD | 0.00% | +14.29% | +33.33% |
30/04 | IBC Advanced Alloys Corp. Announces Entering into Sale Leaseback Agreements | CI |
29/04 | Transcript : IBC Advanced Alloys Corp. - Special Call |
1st Jan change | Capi. | |
---|---|---|
+33.33% | 6.25M | |
-.--% | 7.12B | |
-8.65% | 7.07B | |
+7.73% | 4.38B | |
-3.05% | 4.09B | |
+31.77% | 3.98B | |
-18.99% | 3.88B | |
+47.95% | 3.79B | |
-3.99% | 3.35B | |
-18.39% | 2.52B |
- Stock Market
- Equities
- IB Stock
- News IBC Advanced Alloys Corp.
- Ibc Advanced Alloys Corp. Wins $7.38 Million in New Orders for Beryllium-Aluminum Aerospace Components from Lockheed Martin